Janet L. Lathey - Concepedia

Author

Janet L. Lathey

Also Known As

J L Lathey, J Lathey, J. L Lathey, J. L. Lathey, JANET L. LATHEY, Janet L Lathey, Janet L. Lathey, Janet Lathey, Janet L. Lathey, Lathey, Janet L.

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Harvard University University of Washington Children's Hospital of Philadelphia University of Miami

About

Janet L. Lathey is an author at University of California San Diego specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	855
2	Allergy	3	3	46
3	Cell Biology	2	2	52
4	Education	1	1	65
5	Epidemiology	1	1	23

Janet L. Lathey

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Barbara Klencke, Mark Matijevic, Robert G. Urban, PubMed VaccinationMucosal VaccinationHigh-grade DysplasiaCervical CancerHuman Papillomavirus Vaccines	2002	230
Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages Janet L. Lathey, Stephen A. Spector Journal of Virology Viral PersistenceNeurovirologyMedicineImmunologyViral Pathogenesis	1991	163
Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral Therapy Patricia M. Flynn, Bret J. Rudy, Steven D. Douglas, The Journal of Infectious Diseases	2004	101
Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-Up Patricia M. Flynn, Bret J. Rudy, Jane C. Lindsey, AIDS Research and Human Retroviruses PsychotherapyPactg 381ImmunologyEducationMental Health	2007	65
Lack of Autologous Neutralizing Antibody to Human Immunodeficiency Virus Type 1 (HIV‐1) and Macrophage Tropism Are Associated with Mother‐to‐Infant Transmission Janet L. Lathey, Jeff Tsou, Karen G. Brinker, The Journal of Infectious Diseases Primary ImmunodeficiencyMaternal ImmunizationHiv-1 StrainsHiv-1 RnaNeurovirology	1999	57
Virologic Markers of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid Stephen A. Spector, Karen Hsia, D.L. Pratt, The Journal of Infectious Diseases Primary ImmunodeficiencyDiagnostic VirologyCsf SamplesNeurovirologyCsf Culture	1993	53
Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus Janet L. Lathey, Clayton A. Wiley, M. Anthony Verity, Virology Viral PersistenceViral PathogenesisImmunologyAntiviral ResponseVirology	1990	52
Variability and Prognostic Values of Virologic and CD4 Cell Measures in Human Immunodeficiency Virus Type 1‐Infected Patients with 200–500 CD4 Cells/mm<sup>3</sup>(ACTG 175) Janet L. Lathey, Michael D. Hughes, Susan A. Fiscus, The Journal of Infectious Diseases	1998	47
Prognostic Value of Baseline Human Immunodeficiency Virus Type 1 DNA Measurement for Disease Progression in Patients Receiving Nucleoside Therapy Camlin Tierney, Janet L. Lathey, Cindy Christopherson, The Journal of Infectious Diseases	2002	46
Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates Peter Reinhardt, Barbara Reinhardt, Janet L. Lathey, Journal of Clinical Microbiology Primary ImmunodeficiencySi Isolate Hiv-1laiViral PersistenceHuman RetrovirusSi Hiv-1 Strains	1995	46

Page 1